Two objections come up more or less every time opioid agonist therapy is raised. The first is that it amounts to trading one drug for another. The second is that it means being tied to a pharmacy or a clinic indefinitely. Both deserve a straight answer, because between them they keep a large number of men away from the most effective treatment medicine currently has for opioid use disorder.
The short version is that these medications work by making the opioid receptor system stable rather than by producing a high, and that stability is precisely what allows normal life to resume. Men on treatment hold jobs, drive, parent, and go back to work at camp. The dose is not something they think about between appointments any more than a man on blood pressure medication thinks about his.
What the Medications Do
Short-acting opioids create peaks and troughs. Every dose brings a rise, then a fall into withdrawal and craving several hours later, and the day organises itself around preventing that fall. It is the swing, more than the drug itself, that consumes a person’s life.
Methadone is a long-acting full opioid agonist. Taken once daily, it holds receptor activity at an even level across twenty-four hours, so the peaks and troughs flatten out. Buprenorphine, the active component of Suboxone, works differently again: it is a partial agonist that binds very tightly to the receptor but produces a limited effect no matter how much is taken. That ceiling makes it considerably safer in overdose, and its tight binding blocks other opioids from having much effect. The naloxone included in the combination tablet is inactive when the tablet is dissolved under the tongue as intended, and is there purely to discourage injection.
Neither medication produces euphoria at a stable maintenance dose in someone with tolerance. This is the point most often missed. Men starting treatment sometimes expect to feel sedated or altered and are surprised to feel, as many describe it, simply normal — no withdrawal, no craving, no clock-watching.
Starting Treatment and What It Requires
Starting buprenorphine has traditionally required arriving in mild withdrawal, since giving it too early can displace other opioids and precipitate withdrawal abruptly. Modern approaches include low-dose starts that avoid that problem, and the method chosen depends on what someone has been using — particularly relevant now that fentanyl behaves differently from older opioids. Methadone is started low and increased gradually over weeks, because it accumulates in the body and rushing it is unsafe.
Early on, doses are usually witnessed at a pharmacy. As things stabilise, take-home doses are extended, and many men eventually collect a supply much as they would any other prescription. Ongoing care means periodic appointments, occasional urine testing as part of routine monitoring rather than as a disciplinary measure, and attention to whatever else is going on: pain, sleep, depression, anxiety, or the trauma that frequently sits underneath long-term opioid use.
There is no fixed end date, and no requirement to taper by a particular point. Some men come off after a year or two. Many stay on treatment long-term, which is a reasonable clinical choice rather than a failure — the risk of returning to an unpredictable and fentanyl-contaminated supply is considerable, and treatment substantially reduces the risk of dying.
Answering the Two Objections
On the substitution question: dependence and addiction are not the same thing. Physical dependence on a stable, prescribed, long-acting medication that produces no intoxication and no compulsive use has almost nothing in common with a disorder that consumes a person’s finances, health and relationships. The functional difference is the whole point.
On the commitment question: appointments and pharmacy visits are a genuine imposition, particularly for men working rotations. That is worth discussing openly at the outset, because schedules can usually be worked around, and it is a smaller obstacle than most people assume before asking.
Dr. Isaac Klein provides opioid agonist therapy and broader addiction care at Grande Prairie Men’s Medical Clinic. Appointments can be made at gpmm.clinic or by phoning (587) 416-8296. This article is general information and is not a replacement for assessment by a physician.